Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 25;16(8):e0010704.
doi: 10.1371/journal.pntd.0010704. eCollection 2022 Aug.

Molecular characterization of circulating Salmonella Typhi strains in an urban informal settlement in Kenya

Affiliations

Molecular characterization of circulating Salmonella Typhi strains in an urban informal settlement in Kenya

Caroline Ochieng et al. PLoS Negl Trop Dis. .

Abstract

A high burden of Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) bacteremia has been reported from urban informal settlements in sub-Saharan Africa, yet little is known about the introduction of these strains to the region. Understanding regional differences in the predominant strains of S. Typhi can provide insight into the genomic epidemiology. We genetically characterized 310 S. Typhi isolates from typhoid fever surveillance conducted over a 12-year period (2007-2019) in Kibera, an urban informal settlement in Nairobi, Kenya, to assess the circulating strains, their antimicrobial resistance attributes, and how they relate to global S. Typhi isolates. Whole genome multi-locus sequence typing (wgMLST) identified 4 clades, with up to 303 pairwise allelic differences. The identified genotypes correlated with wgMLST clades. The predominant clade contained 290 (93.5%) isolates with a median of 14 allele differences (range 0-52) and consisted entirely of genotypes 4.3.1.1 and 4.3.1.2. Resistance determinants were identified exclusively in the predominant clade. Determinants associated with resistance to aminoglycosides were observed in 245 isolates (79.0%), sulphonamide in 243 isolates (78.4%), trimethoprim in 247 isolates (79.7%), tetracycline in 224 isolates (72.3%), chloramphenicol in 247 isolates (79.6%), β-lactams in 239 isolates (77.1%) and quinolones in 62 isolates (20.0%). Multidrug resistance (MDR) determinants (defined as determinants conferring resistance to ampicillin, chloramphenicol and cotrimoxazole) were found in 235 (75.8%) isolates. The prevalence of MDR associated genes was similar throughout the study period (2007-2012: 203, 76.3% vs 2013-2019: 32, 72.7%; Fisher's Exact Test: P = 0.5478, while the proportion of isolates harboring quinolone resistance determinants increased (2007-2012: 42, 15.8% and 2013-2019: 20, 45.5%; Fisher's Exact Test: P<0.0001) following a decline in S. Typhi in Kibera. Some isolates (49, 15.8%) harbored both MDR and quinolone resistance determinants. There were no determinants associated with resistance to cephalosporins or azithromycin detected among the isolates sequenced in this study. Plasmid markers were only identified in the main clade including IncHI1A and IncHI1B(R27) in 226 (72.9%) isolates, and IncQ1 in 238 (76.8%) isolates. Molecular clock analysis of global typhoid isolates and isolates from Kibera suggests that genotype 4.3.1 has been introduced multiple times in Kibera. Several genomes from Kibera formed a clade with genomes from Kenya, Malawi, South Africa, and Tanzania. The most recent common ancestor (MRCA) for these isolates was from around 1997. Another isolate from Kibera grouped with several isolates from Uganda, sharing a common ancestor from around 2009. In summary, S. Typhi in Kibera belong to four wgMLST clades one of which is frequently associated with MDR genes and this poses a challenge in treatment and control.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. wgMLST tree of 310 isolates of S. Typhi isolates collected in the Kibera settlement in Kenya colected from 2007–2019.
Displayed outside the tree (from inside to out) are the presence of antimicrobial resistance determiants (filled boxes in red), the presence of plasmid markers (filled blue boxes), genotyphi genotypes, and the year of isolation.
Fig 2
Fig 2. Temporal trends in genotype and antibiotic resistance by year of isolation.
The top panel displays the genotype by year of isolation, where the x-axis is the year of isolation and the y-axis is count of isolates from that year belonging to each genotype. The bottom panel displays resistance information, where detection of determinants for a particular antimicrobial were employed as a proxy for resistance. The red line illustrates the percent of isolates over time with genes conferring resistance to ampicillin, chloramphenicol, and sulfa-methoxazole (defined as MDR). The blue line illustrates the percent of isolates with fluroquinolone resistance determinants.
Fig 3
Fig 3. Global context of 4.3.1 genomes from Kibera using a molecular clock analysis.
Tip dated maximum clade credibility tree of 148 isolates of S. Typhi genotype 4.3.1 generated using BEAST2. This analysis includes 8 isolates from the Kibera settlement in Kenya sequenced as part of the present study, 10 isolates from Uganda, and the remaining isolates are from two previous studies of the phylogeography of S. Typhi published by Wong et al (2015) and Park et al. (2018). The x-axis denotes calendar year. The tree is colored by location, with isolates from Kenya highlighted in red. Tip labels include the isolate ID and accession ID separated by an underscore. The country from which the sample was isolated from is also displayed. Posterior support for internal nodes are displayed where values are >0.70. Grey horizontal bars indicate the 95% Highest Posterior Density (HPD) Interval for height of the given clade (corresponds to age). Colored star markers on the x-axis indicate relevant epidemiological events. Red stars indicate typhoid outbreaks in Uganda, and the blue star marks when improvements in water sanitation were made in Kibera [50].

Similar articles

Cited by

References

    1. World Health Organization. Typhoid vaccines: WHO position paper, March 2018—Recommendations. Vaccine. 2019. Jan 7;37(2):214–6. doi: 10.1016/j.vaccine.2018.04.022 - DOI - PubMed
    1. Britto CD, Wong VK, Dougan G, Pollard AJ. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Negl Trop Dis. 2018. Oct;12(10):e0006779. doi: 10.1371/journal.pntd.0006779 - DOI - PMC - PubMed
    1. Olarte J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother. 1973. Dec;4(6):597–601. doi: 10.1128/AAC.4.6.597 - DOI - PMC - PubMed
    1. Smith SM, Palumbo PE, Edelson PJ. Salmonella strains resistant to multiple antibiotics: therapeutic implications. Pediatr Infect Dis. 1984. Oct;3(5):455–60. doi: 10.1097/00006454-198409000-00017 - DOI - PubMed
    1. Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998–2012. Int J Med Microbiol IJMM. 2017 Jan;307(1):28–36. doi: 10.1016/j.ijmm.2016.11.006 - DOI - PubMed

Publication types